Lyra Therapeutics (LYRA) Insider Trading & Ownership $8.48 -0.23 (-2.64%) Closing price 04:00 PM EasternExtended Trading$8.45 -0.03 (-0.35%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lyra Therapeutics (NASDAQ:LYRA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.25%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$20.04K Get LYRA Insider Trade Alerts Want to know when executives and insiders are buying or selling Lyra Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address LYRA Insider Buying and Selling by Quarter Lyra Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/10/2025Jason CavalierCFOSell684$8.91$6,094.44 7/10/2025Maria PalasisCEOSell1,565$8.91$13,944.15 (Data available from 1/1/2013 forward) LYRA Insider Trading Activity - Frequently Asked Questions Who is on Lyra Therapeutics' Insider Roster? The list of insiders at Lyra Therapeutics includes Harlan Waksal, Jason Cavalier, Maria Palasis, Nbvm Gp, Llc, and Perceptive Advisors Llc. Learn more on insiders at LYRA. What percentage of Lyra Therapeutics stock is owned by insiders? 3.25% of Lyra Therapeutics stock is owned by insiders. Learn more on LYRA's insider holdings. Which Lyra Therapeutics insiders have been buying company stock? The following insider purchased LYRA shares in the last 24 months: Harlan Waksal ($74,000.00). How much insider buying is happening at Lyra Therapeutics? Insiders have purchased a total of 500 LYRA shares in the last 24 months for a total of $74,000.00 bought. Which Lyra Therapeutics insiders have been selling company stock? The following insiders have sold LYRA shares in the last 24 months: Jason Cavalier ($6,094.44), and Maria Palasis ($13,944.15). How much insider selling is happening at Lyra Therapeutics? Insiders have sold a total of 2,249 Lyra Therapeutics shares in the last 24 months for a total of $20,038.59 sold. Lyra Therapeutics Key ExecutivesDr. Harlan W. Waksal M.D. (Age 71)Executive Chairman Compensation: $210.06kDr. Maria Palasis Ph.D. (Age 59)CEO, President & Director Compensation: $942.7kDr. John E. Bishop Ph.D. (Age 62)Chief Technology Officer Compensation: $662.9kDr. Carmichael S. Roberts Jr. (Age 55)Ph.D., Co-Founder Mr. Jason Cavalier (Age 51)CFO, Treasurer & Secretary Compensation: $464.11k1 recent tradesMr. Ray KnoxVice President of OperationsMs. Ellen CavaleriSenior Vice President of Investor Relations & CommunicationsMr. Ronan P. O'Brien J.D. (Age 51)Chief Legal Officer Ms. Corinne Noyes (Age 56)Senior Vice President of Commercial Strategy & Market Development Compensation: $426.73kMs. Vineeta Belanger Ph.D.Senior Vice President of Clinical Affairs More Insider Trading Tools from MarketBeat Related Companies DXR Insider Trading ECOR Insider Trading NEPH Insider Trading MODD Insider Trading QTI Insider Trading POCI Insider Trading NMTC Insider Trading COCH Insider Trading DRIO Insider Trading NUWE Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling Hits Market Leaders—Should You Be Worried?3 Small Caps Drawing Insider and Institutional SupportDo They Know Something? Insiders & Congress Buy UnitedHealthMicron Insiders Sell But Investors Should Buy, Buy, BuySizzling Insider Buys for Your High-Yield Watchlist This page (NASDAQ:LYRA) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lyra Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lyra Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
